Andere Sprachen InterCure Ltd.

Aktien

A1CZA8

IL0011063760

INCR

Verzögert TEL AVIV STOCK EXCHANGE Andere Börsenplätze 15:45:05 01.05.2024			% 5 Tage	% 1. Jan.
1.154 ^ILa	+14,48 %		+15,99 %	+148,54 %

01.04.	InterCure Ltd. gibt Gewinnprognose für das zweite Halbjahr und das Gesamtjahr 2023 ab	CI
22.03.	InterCure Ltd. erwartet die Markteinführung der ersten Produkte in Deutschland in den kommenden Monaten	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million	14:28
InterCure : FORM 20-F For the fiscal year ended December 31, 2023	13:31
InterCure : Announces FY2023 Result	13:31
InterCure : Preliminary results for the full year of 2023	01.04.
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million	01.04.
InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023	01.04.
InterCure : Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBIDTA of over NIS 50 million - Form 6-K	01.04.
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint	22.03.
InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months	22.03.
InterCure Provides an Update Regarding Nir Oz Facility	13.02.
InterCure Ltd. Announces Resignation of Rami Levy as Chief of Operations	13.02.
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain	31.01.
InterCure Ltd. entered into a share purchase agreement to acquire Leon Pharm Ltd for ILS 8.3 million.	31.01.
InterCure : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 14, 2023 - Form 6-K	08.11.
InterCure Wins Cannolam Arbitration Proceeding	31.10.23
InterCure Provides an Update Regarding the Security Situation in Israel	17.10.23
InterCure Ltd.(TASE:INCR) dropped from S&P Global BMI Index	18.09.23
InterCure : Other Report or Announcement	01.09.23
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY	01.09.23
InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	01.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen InterCure Ltd.

Aktien

A1CZA8

IL0011063760

INCR

Andere Sprachen

Filter